Open access · OA
via OpenAlex
Inflammatory Biomarkers In Early Detection Of Acute Coronary Syndrome
Muhammad Faheem Khan, Farooq Ahmad, Awais Farhad, Muhammad Habeel Dar, Zeeshan Ahmad, Shafiq Ahmad
Journal of Pharmaceutical Negative Results · 2022
Abstract
Background Acute Coronary Syndrome (ACS) encompasses conditions that result from the sudden blockage of blood flow to the heart, often caused by a ruptured atherosclerotic plaque. Inflammatory processes are pivotal in the pathogenesis of ACS. Detection of specific inflammatory biomarkers has the potential to enhance early diagnosis and improve patient outcomes by identifying at-risk individuals earlier in the disease process.. Objectives To assess the role of inflammatory biomarkers in the early detection of ACS, improving diagnostic accuracy and patient management. Methodology This observational descriptive study was conducted involving patients presenting with chest pain and suspected ACS, at Department of Cardiology , Khyber Teaching Hospital, Peshawar from Jan 2020 to Jan 2021. Blood samples were analyzed for inflammatory biomarkers, including CRP, interleukins, and white blood cell count. Statistical analysis was performed to evaluate the significance of these biomarkers in diagnosing ACS. Results A total of 150 patients participated, with a mean age of 58.3 years (SD: 10.2). CRP and interleukin-6 (IL-6) levels were significantly elevated in patients with ACS suggesting a strong inflammatory component in the onset of ACS. The biomarkers provided additional diagnostic value when combined with traditional methods. Conclusion Inflammatory biomarkers such as CRP and IL-6 offer significant potential for the early detection of ACS, aiding in more accurate diagnosis and better clinical decision-making. These biomarkers can improve risk stratification and guide timely interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.47750/wnzjtq58
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Ahmad, M.F.K.F.A.A.F.M.H.D.Z.A.S. (2022). Inflammatory Biomarkers In Early Detection Of Acute Coronary Syndrome. <em>Journal of Pharmaceutical Negative Results</em>. https://doi.org/10.47750/wnzjtq58
Vancouver
Ahmad MFKFAAFMHDZAS. Inflammatory Biomarkers In Early Detection Of Acute Coronary Syndrome. Journal of Pharmaceutical Negative Results. 2022. doi:10.47750/wnzjtq58.
BibTeX
@article{muhammad2022Inflam,
title = {Inflammatory Biomarkers In Early Detection Of Acute Coronary Syndrome},
author = {Muhammad Faheem Khan, Farooq Ahmad, Awais Farhad, Muhammad Habeel Dar, Zeeshan Ahmad, Shafiq Ahmad},
journal = {Journal of Pharmaceutical Negative Results},
year = {2022},
doi = {10.47750/wnzjtq58},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational Pediatrics 2026
Open access · CC-BY
Inflammatory cytokines as biomarkers for disease severity in pediatric viral pneumonia: a systematic review and meta-analysis
Diabetes Metabolic Syndrome and Obesity 2020
Open access · CC-BY
Salivary Amylase Gene Copy Number Is Associated with the Obesity and Inflammatory Markers in Children
ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS 2025
Open access · CC-BY
INTERLEUKIN-6 AND ACUTE PHASE PROTEINS AS BIOMARKERS OF SEPTIC OSTEOARTHRITIS
Translational Vision Science & Technology 2020
Open access · CC-BY
Inflammasome Proteins as Inflammatory Biomarkers of Age-Related Macular Degeneration
International Journal of Medical Sciences 2015
Open access · CC-BY
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Indian Journal of Pharmaceutical and Biological Research 2026
Open access · CC-BY